Scholarly Works - Conferences
Conference
Blood
·
November 13, 2019
Background: Individuals with acute myeloid leukemia (AML) are at risk for significant physical and psychological burden related to their illness. While overall survival rates are improving, treatments may be associated with lengthy hospitalizations ...
Full text
Cite
Conference
Blood
·
November 13, 2019
BACKGROUND: The incidence of AML is increasing, in part due to the overall aging population; median age at presentation is 67 years. Overall 5-year survival rates are as low as 5%-10% in adults >60 years (Wang, 2014). While standard treatment fo ...
Full text
Cite
Conference
Journal of Clinical Oncology
·
November 1, 2019
105 Background: The incidence of AML is increasing, in part due to an aging population. Amid established intravenous (IV) or subcutaneous chemotherapies , recent drug approvals have ushered in an era of oral medication (OM) appro ...
Full text
Cite
